Philosys Healthcare Rises 7.28% Amid COVID-19 (Diagnostic Kit) Theme Uptrend

On the 6th, the COVID-19 (diagnostic kit) theme showed strength by rising 3.50% compared to the previous day, with Philosis Healthcare, a related stock drawing attention, soaring 7.28% from the previous day. Philosis Healthcare is known as a specialized manufacturer of digital set-top boxes.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to provisional data compiled at 13:41, foreign investors have sold -33,000 shares of Philosis Healthcare, indicating a large net sell-off by foreigners.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Philosis Healthcare’s quant financial score is 0.23 points, which is lower in stability, profitability, and growth compared to the average of other stocks related to COVID-19 (diagnostic kits). This can be interpreted as Philosis Healthcare having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Huons ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of analysis by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.